StockWatch
·
Pharmaceuticals
Board Meeting22 Oct 2026, 05:00 pm

Divis Laboratories Board Meeting on Nov 7, 2026 for Unaudited Results

AI Summary

Divis Laboratories Ltd has announced that its Board of Directors will convene on November 7, 2026. The primary agenda item for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. In line with SEBI regulations, the trading window for the company's securities has been closed from October 1, 2026, and will remain shut until 48 hours after the financial results are declared, extending the closure until November 9, 2026.

Key Highlights

  • Board meeting scheduled for November 7, 2026.
  • To approve unaudited financial results for Q2 FY27.
  • Results will cover both standalone and consolidated financials.
  • Trading window closed until November 9, 2026.